Ovarian cancer is often asymptomatic in its early stages, making early detection challenging. Biomarkers like CA-125 and HE4 are critical for screening and early detection. These markers can also be used to monitor the disease's progression and response to treatment. Combining multiple biomarkers improves the accuracy of ovarian cancer diagnosis.
